Genedx Holdings Corp (WGS)

$59.75

-0.25

(-0.42%)▲

Market is closed - opens 7 PM, 15 Oct 2024

Performance

  • $57.30
    $60.55
    $59.75
    downward going graph

    4.1%

    Downside

    Day's Volatility :5.36%

    Upside

    1.32%

    downward going graph
  • $1.16
    $60.80
    $59.75
    downward going graph

    98.06%

    Downside

    52 Weeks Volatility :98.09%

    Upside

    1.73%

    downward going graph

Returns

PeriodGenedx Holdings CorpIndex (Russel 2000)
3 Months
73.91%
0.0%
6 Months
507.29%
0.0%
1 Year
1751.85%
0.0%
3 Years
629.93%
-22.2%

Highlights

Market Capitalization
1.5B
Book Value
$7.21
Earnings Per Share (EPS)
-4.38
Wall Street Target Price
40.83
Profit Margin
-48.21%
Operating Margin TTM
-15.0%
Return On Assets TTM
-12.2%
Return On Equity TTM
-47.93%
Revenue TTM
243.7M
Revenue Per Share TTM
9.33
Quarterly Revenue Growth YOY
44.800000000000004%
Gross Profit TTM
-26.8M
EBITDA
-65.8M
Diluted Eps TTM
-4.38
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.78
EPS Estimate Next Year
0.09
EPS Estimate Current Quarter
-0.3
EPS Estimate Next Quarter
-0.25

Analyst Recommendation

Buy
    62%Buy
    37%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Genedx Holdings Corp(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
5
5
5
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Downside of 31.67%

Current $59.75
Target $40.83

Company Financials

FY19Y/Y Change
Revenue
196.2M
-
Net Income
-31.0M
-
Net Profit Margin
-15.8%
-
FY20Y/Y Change
Revenue
179.3M
↓ 8.59%
Net Income
-246.4M
↑ 695.19%
Net Profit Margin
-137.43%
↓ 121.63%
FY21Y/Y Change
Revenue
212.2M
↑ 18.33%
Net Income
-245.4M
↓ 0.42%
Net Profit Margin
-115.64%
↑ 21.79%
FY22Y/Y Change
Revenue
234.7M
↑ 10.6%
Net Income
-549.0M
↑ 123.72%
Net Profit Margin
-233.91%
↓ 118.27%
FY23Y/Y Change
Revenue
202.6M
↓ 13.69%
Net Income
-175.8M
↓ 67.98%
Net Profit Margin
-86.77%
↑ 147.14%
Q1 FY23Q/Q Change
Revenue
43.1M
↓ 29.68%
Net Income
-61.0M
↓ 80.25%
Net Profit Margin
-141.38%
↑ 361.9%
Q2 FY23Q/Q Change
Revenue
48.7M
↑ 12.9%
Net Income
-46.7M
↓ 23.4%
Net Profit Margin
-95.92%
↑ 45.46%
Q3 FY23Q/Q Change
Revenue
53.3M
↑ 9.44%
Net Income
-42.3M
↓ 9.49%
Net Profit Margin
-79.33%
↑ 16.59%
Q4 FY23Q/Q Change
Revenue
57.4M
↑ 7.72%
Net Income
-25.8M
↓ 39.05%
Net Profit Margin
-44.89%
↑ 34.44%
Q1 FY24Q/Q Change
Revenue
62.4M
↑ 8.72%
Net Income
-20.2M
↓ 21.47%
Net Profit Margin
-32.42%
↑ 12.47%
Q2 FY24Q/Q Change
Revenue
70.5M
↑ 12.96%
Net Income
-29.2M
↑ 44.14%
Net Profit Margin
-41.37%
↓ 8.95%
FY20Y/Y Change
Total Assets
251.6M
-
Total Liabilities
581.7M
-
FY21Y/Y Change
Total Assets
554.1M
↑ 120.19%
Total Liabilities
166.0M
↓ 71.46%
FY22Y/Y Change
Total Assets
490.9M
↓ 11.4%
Total Liabilities
237.2M
↑ 42.92%
FY23Y/Y Change
Total Assets
473.7M
↓ 3.52%
Total Liabilities
245.7M
↑ 3.55%
Q1 FY23Q/Q Change
Total Assets
545.3M
↑ 11.07%
Total Liabilities
216.8M
↓ 8.6%
Q2 FY23Q/Q Change
Total Assets
476.4M
↓ 12.64%
Total Liabilities
180.3M
↓ 16.86%
Q3 FY23Q/Q Change
Total Assets
417.3M
↓ 12.41%
Total Liabilities
163.0M
↓ 9.57%
Q4 FY23Q/Q Change
Total Assets
473.7M
↑ 13.51%
Total Liabilities
245.7M
↑ 50.68%
Q1 FY24Q/Q Change
Total Assets
394.5M
↓ 16.71%
Total Liabilities
187.3M
↓ 23.75%
Q2 FY24Q/Q Change
Total Assets
389.1M
↓ 1.38%
Total Liabilities
195.1M
↑ 4.14%
FY19Y/Y Change
Operating Cash Flow
-18.7M
-
Investing Cash Flow
-15.5M
-
Financing Cash Flow
148.0M
-
FY20Y/Y Change
Operating Cash Flow
-93.1M
↑ 397.27%
Investing Cash Flow
-32.0M
↑ 106.87%
Financing Cash Flow
129.1M
↓ 12.81%
FY21Y/Y Change
Operating Cash Flow
-190.4M
↑ 104.49%
Investing Cash Flow
-20.8M
↓ 34.99%
Financing Cash Flow
493.7M
↑ 282.57%
FY22Y/Y Change
Operating Cash Flow
-319.2M
↑ 67.59%
Investing Cash Flow
-141.3M
↑ 579.91%
Financing Cash Flow
197.3M
↓ 60.04%
Q1 FY23Q/Q Change
Operating Cash Flow
-55.6M
↓ 14.07%
Investing Cash Flow
-462.0K
↓ 83.72%
Financing Cash Flow
132.7M
↑ 203989.23%
Q2 FY23Q/Q Change
Operating Cash Flow
-53.5M
↓ 3.71%
Investing Cash Flow
-11.3M
↑ 2339.61%
Financing Cash Flow
7.4M
↓ 94.43%

Technicals Summary

Sell

Neutral

Buy

Genedx Holdings Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Genedx Holdings Corp
Genedx Holdings Corp
59.07%
507.29%
1751.85%
629.93%
512.24%
Solventum Corp
Solventum Corp
-5.08%
10.46%
-1.39%
-1.39%
-1.39%
Doximity, Inc.
Doximity, Inc.
9.81%
70.38%
94.74%
-42.73%
-18.28%
Veeva Systems Inc.
Veeva Systems Inc.
-2.63%
4.81%
-0.3%
-31.45%
37.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
5.07%
5.69%
36.11%
50.49%
50.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Genedx Holdings Corp
Genedx Holdings Corp
1.83
NA
NA
-0.78
-0.48
-0.12
NA
7.21
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Doximity, Inc.
Doximity, Inc.
54.14
54.14
2.42
0.9
0.17
0.11
NA
4.92
Veeva Systems Inc.
Veeva Systems Inc.
56.5
56.5
1.21
4.76
0.13
0.06
NA
32.04
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
26.08
26.08
2.37
4.25
0.21
0.06
0.0
17.08
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Genedx Holdings Corp
Genedx Holdings Corp
Buy
$1.5B
512.24%
1.83
-48.21%
Solventum Corp
Solventum Corp
Hold
$10.8B
-1.39%
NA
15.73%
Doximity, Inc.
Doximity, Inc.
Hold
$8.0B
-18.28%
54.14
32.53%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$34.2B
37.91%
56.5
23.91%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$41.2B
50.49%
26.08
8.1%

Insights on Genedx Holdings Corp

  • Increasing Revenue

    Revenue is up for the last 6 quarters, 43.13M → 70.51M (in $), with an average increase of 9.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -20.23M → -29.17M (in $), with an average decrease of 44.1% per quarter

Company Information

Organization
Genedx Holdings Corp
Employees
1000
CEO
Ms. Katherine A. Stueland
Industry
Healthcare

Discover More

FAQs